NCT05975736

Brief Summary

Brief Summary A task like breast cancer screening (mammography) can be described as a "hybrid search" task. In basic visual search tasks, observers search for a target among distractors that are not the target. In hybrid search, observers search for two or more target types. In mammography, observers are searching for masses, calcifications ("calcs"), and some other signs of cancer like architectural distortion. In this experiment, the investigators have created a simulated version of mammography where non-expert (non-radiologist) observers can look for simulated masses and calcs. There are two types of stimuli, a 2D version (like an x-ray) and a 3D version (like the output of Digital Breast Tomosynthesis - DBT). The question that is being asked is whether it is better to ask about masses and calcs separately (first one, then the other) or to just let observers look for both at the same time.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
28mo left

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Sep 2022Sep 2028

Study Start

First participant enrolled

September 1, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 4, 2023

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

February 19, 2025

Status Verified

February 1, 2025

Enrollment Period

5 years

First QC Date

July 27, 2023

Last Update Submit

February 16, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Time required to respond to a case

    The measure of response time is an index of the difficulty of each case.

    Through study completion, an average of 1 year

  • Rates of false positive and false negative errors

    Cases are either positive or negative for simulated cancer. Responses are either correct or incorrect in identifying if the case is positive or negative. Hence each response is either a true or false positive and or a true or false negative response. The relative percentages of these errors provides a measure of accuracy.

    through study completion, an average of 1 year

Study Arms (2)

Blocked Trials

EXPERIMENTAL

There are four conditions in the experiment. Each condition will be presented in a separate block of 100 trials.

Behavioral: Search only for massesBehavioral: Search only for calcificationsBehavioral: Search for both togetherBehavioral: Search for one after the other

Mixed Trials

EXPERIMENTAL

There are four conditions in the experiment. All condition will be presented, randomly mixed in a single block of 400 trials (with breaks every 100 trials).

Behavioral: Search only for massesBehavioral: Search only for calcificationsBehavioral: Search for both togetherBehavioral: Search for one after the other

Interventions

Participants search the simulated mammogram for simulated masses.

Blocked TrialsMixed Trials

Participants search the simulated mammogram for simulated calcifications.

Blocked TrialsMixed Trials

Search the simulated mammogram for both simulated masses and simulated calcifications at the same time.

Blocked TrialsMixed Trials

Search the simulated mammogram for first for simulated masses and then for simulated calcifications sequentially (or vice versa).

Blocked TrialsMixed Trials

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 yrs
  • Pass Ishihara color vision test

You may not qualify if:

  • vision less than 20/25 with correction
  • history of neuromuscular or visual disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Calcification, Physiologic

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

BiomineralizationGrowth and DevelopmentPhysiological PhenomenaBone DevelopmentMusculoskeletal DevelopmentOrganogenesisEmbryonic and Fetal DevelopmentMorphogenesisMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jeremy M Wolfe, PhD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants will not know the goals of the study but they will be fully informed about the conditions and asked to respond "as quickly and accurately as possible".
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: One group of observers will get separate blocks of each of four conditions. The other group will see all conditions, intermixed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 27, 2023

First Posted

August 4, 2023

Study Start

September 1, 2022

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2028

Last Updated

February 19, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

De-identified data are posted on the Open Science Framework

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
As soon as data collection and analysis is complete. Data will be available "forever"
Access Criteria
Open

Locations